# Princeton Bancorp, Inc.: overview BPRN · Nasdaq · CIK 1913971 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/bprn.md) · [Financials](/companies/bprn/financials.md) · [Filings](/companies/bprn/filings.md) · [Insiders](/companies/bprn/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [(0.68)](/filings/0001193125-25-272371.md) | not reported | [0.77](/filings/0001193125-26-214214.md) | [0.10](/filings/0001193125-26-339937.md) | [0.95](/filings/0001193125-25-272371.md) | not reported | [0.91](/filings/0001193125-26-214214.md) | [1.04](/filings/0001193125-26-339937.md) | | Free cash flow | $m | [0.8 d](/filings/0001193125-25-272371.md) | [3.8 d](/filings/0001193125-26-106151.md) | [1.1](/filings/0001193125-26-214214.md) | [2.9 d](/filings/0001193125-26-339937.md) | [4.7 d](/filings/0001193125-25-272371.md) | [12.0 d](/filings/0001193125-26-106151.md) | [4.9](/filings/0001193125-26-214214.md) | [1.8 d](/filings/0001193125-26-339937.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [3.30](/filings/0001193125-23-079231.md) | [4.11](/filings/0001193125-24-076546.md) | [4.03](/filings/0001193125-25-054907.md) | [1.55](/filings/0001193125-26-106151.md) | [2.71](/filings/0001193125-26-106151.md) | | Free cash flow | $m | [11.7](/filings/0001193125-23-079231.md) | [23.4](/filings/0001193125-24-076546.md) | [21.4](/filings/0001193125-25-054907.md) | [13.2](/filings/0001193125-26-106151.md) | [20.6](/filings/0001193125-26-106151.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/bprn/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [ALLIANCEBERNSTEIN L.P.](/funds/1109448.md) | 2026-06-30 | $18.4m | 544,129 | | Reduced −16,410 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $16.2m | 427,681 | | Added +59,371 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $8.2m | 216,010 | | Reduced −35,325 | | [SYSTEMATIC FINANCIAL MANAGEMENT LP](/funds/1085936.md) | 2026-06-30 | $7.6m | 201,531 | | Reduced −37,356 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $6.6m | 173,450 | | Added +13,067 | | [BANC FUNDS CO LLC](/funds/1029311.md) | 2026-06-30 | $5.8m | 153,926 | | Unchanged | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $5.0m | 132,551 | | Added +8,242 | | [ROYCE & ASSOCIATES LP](/funds/906304.md) | 2026-06-30 | $3.8m | 100,389 | | Added +19,919 | | [BASSWOOD CAPITAL MANAGEMENT, L.L.C.](/funds/1085393.md) | 2026-06-30 | $3.7m | 97,529 | | Added +5,841 | | [BRIDGEWAY CAPITAL MANAGEMENT, LLC](/funds/1107261.md) | 2026-06-30 | $2.8m | 73,981 | | Reduced −366 | ## Recent filings [All 363 filings](/companies/bprn/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-07 | 18:05 ET | [10-Q](/filings/0001193125-26-339937.md) | Quarterly report, period 2026-06-30 | 0001193125-26-339937 | | 2026-07-23 | 20:00 ET | [8-K](/filings/0001193125-26-314061.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-314061 | | 2026-07-22 | 20:00 ET | [8-K](/filings/0001193125-26-312374.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-312374 | | 2026-05-08 | 18:20 ET | [10-Q](/filings/0001193125-26-214214.md) | Quarterly report, period 2026-03-31 | 0001193125-26-214214 | | 2026-04-27 | 21:02 ET | [8-K](/filings/0001193125-26-182356.md) | 5.07 Shareholder vote results | 0001193125-26-182356 | | 2026-04-23 | 20:00 ET | [8-K](/filings/0001193125-26-173619.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-173619 | | 2026-04-21 | 20:04 ET | [8-K](/filings/0001193125-26-166724.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-166724 | | 2026-04-06 | 19:31 ET | [10-K/A](/filings/0001193125-26-143612.md) | Annual report, amended, period 2025-12-31 | 0001193125-26-143612 | | 2026-03-26 | 19:25 ET | [DEF 14A](/filings/0001193125-26-126059.md) | Proxy statement, period 2026-04-21 | 0001193125-26-126059 | | 2026-03-13 | 20:12 ET | [10-K](/filings/0001193125-26-106151.md) | Annual report, period 2025-12-31 | 0001193125-26-106151 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-106151.md), filed Mar 13, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1913971 - Tickers: BPRN - Exchange: Nasdaq - SIC code: 6022 State Commercial Banks - State of incorporation: PA - Filer category: Accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.